
Daniel Diaz
Articles
-
Sep 9, 2024 |
biorxiv.org | Brent Allman |Luiz Vieira |Daniel Diaz |Daniel Díaz |Claus O. Wilke
AbstractPredicting the evolutionary patterns of emerging and endemic viruses is key for mitigating their spread in host populations. In particular, it is critical to rapidly identify mutations with the potential for immune escape or increased disease burden (variants of concern). Knowing which circulating mutations are such variants of concern can inform treatment or mitigation strategies such as alternative vaccines or targeted social distancing.
-
Jul 23, 2024 |
nature.com | Daniel Diaz |Daniel Díaz |James M. Loy |Jordan Wells |Andrew D Ellington
AbstractEngineering stabilized proteins is a fundamental challenge in the development of industrial and pharmaceutical biotechnologies. We present Stability Oracle: a structure-based graph-transformer framework that achieves SOTA performance on accurately identifying thermodynamically stabilizing mutations.
Biosensor and machine learning-aided engineering of an amaryllidaceae enzyme - Nature Communications
Mar 6, 2024 |
nature.com | Simon d’Oelsnitz |Daniel Diaz |Daniel Díaz |Daniel Acosta |James M. Loy |Hal S Alper | +1 more
AbstractA major challenge to achieving industry-scale biomanufacturing of therapeutic alkaloids is the slow process of biocatalyst engineering. Amaryllidaceae alkaloids, such as the Alzheimer’s medication galantamine, are complex plant secondary metabolites with recognized therapeutic value. Due to their difficult synthesis they are regularly sourced by extraction and purification from the low-yielding daffodil Narcissus pseudonarcissus.
-
May 15, 2023 |
biorxiv.org | Daniel Diaz |Daniel Díaz |James M. Loy |Chengyue Gong |Jeffrey Ouyang-Zhang
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →